RNA Drug - Search News

FDA, RNA and Malaria

FDA Places Clinical Hold On BioNTech's Early-Phase Trial For RNA-Based Malaria Vaccine

BioNTech's malaria vaccine trial faces an FDA clinical hold. The company is addressing concerns and collaborating with regulators on next steps.

Seeking Alpha on MSN · 1d

BioNTech SE's RNA-based vaccine for malaria placed on clinical hold by FDA

BioNTech SE (NASDAQ:BNTX) said on Tuesday, that the U.S. Food and Drug Administration informed of a clinical hold on the company's Investigational New Drug application and mid-stage trial evaluating its vaccine for prevention of P.

FierceBiotech · 1d

BioNTech's RNA malaria vaccine trial hit by FDA hold

The FDA has placed a hold on BioNTech’s phase 1/2a trial, pausing the company’s efforts to develop a RNA-based vaccine for malaria prevention. | The FDA has placed a hold on BioNTech’s phase 1/2a trial,

Biotech startup looks to challenge the 'really messy situation' of aging

Drug developers' dreams of silencing RNA as a way to step in front of a range of diseases have not lived up to early-day hype ...

BioSpace9d

RNA Editing Hits the Clinic, Fueling New Hope for Rare and Common Diseases

With the modality now in early clinical trials, experts say more efficiency, broader editing capabilities and delivery ...

technologynetworks9d

Computer Model “Visualizes” RNA Structures To Advance Drug Discovery

Researchers at Purdue University have developed NuFold, a machine learning tool that predicts 3D RNA structures from ...

GEN10h

Africa RNA Vaccine Manufacturing Effort will Use AI and Automation

Automation and artificial intelligence (AI) will be key to a new effort to manufacture millions of RNA vaccines in Africa.

9don MSN

Computational solution to model 3D RNA structures could speed medical discoveries by decades

Ribonucleic acid, commonly known as RNA, is involved in many biological functions, and some, including gene silencing, are ...

Taiwan News10d

RNA-Targeting Small Molecule Drug Discovery Market to Surge Beyond USD 1.1 Billion, Projected 20.9%+ CAGR Through 2030

The global RNA targeting small molecule drug discovery market was valued at approximately USD 1.1 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of more than 20.9% ...

BioTechniques1d

Peek Behind the Paper: RNA extraction and sequencing method for transcriptomic analysis of Mycobacterium tuberculosis

Researchers have developed an RNA-seq method for investigating drug-resistant infections, and we got the inside scoop!

Some results have been hidden because they may be inaccessible to you

Show inaccessible results